Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Inventory Average (2020 - 2021)

VYNE Therapeutics' Inventory Average history spans 2 years, with the latest figure at $7.7 million for Q4 2021.

  • For Q4 2021, Inventory Average rose 9.3% year-over-year to $7.7 million; the TTM value through Dec 2021 reached $7.7 million, up 9.3%, while the annual FY2021 figure was $7.3 million, 67.75% up from the prior year.
  • Inventory Average reached $7.7 million in Q4 2021 per VYNE's latest filing, down from $8.2 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $8.2 million in Q2 2021 to a low of $2.3 million in Q1 2020.